Bacterial Pathogens and Disease - EXOTOXINS Flashcards

1
Q

What is a pathogen?

A

A microorganism capable of causing disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is pathogenicity?

A

The abillity of an infectious agent to cause disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is virulence?

A

The quantitative abillity of an agent to cause disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is toxigenicity?

A

The abillity of a microorganism to produce a toxin which contributes towards the development of diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List some virulence mechanisms

A
  • Adherance factors
  • Biofilms
  • Invasion of host cells and tissues
  • Toxins - endotoxins and exotoxins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are exotoxins?

A

Exotoxins are a group of hetergeneous proteins which are produced and secreted by gram + and gram - living bacterial cells

  • Cause disease symptoms in the host
  • Act via a variety of diverse mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the purpose of bacteria having exotoxins?

A
  • Exotoxins will cause disease → However in a severe disease may cause death meaning bacteria will not be able to replicate and cause an evolutionary dead end
  • However, with many toxins the disease causing activity may not be the primary function others include:
    • Evade immune response of host
    • Enable biofilm formation
    • Enable attachment of host cells
    • Escape from phagosomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What can functions such as evading immune response, biofilm formation, attachment of host cells and escape of phagosomes result in?

A
  • Allow for colonisation, niche establishment and carriage = Evolutionary advantage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Looking at Staphylococcus aureus what toxin does it produce and what are their functions?

A
  • HAEMOLYTIC TOXINS = Causes cells to lyse by forming pores
    • Important feature of S.aureus disease
      • α,β,δ, toxins ,Panton Valentine Leukocidin (PVL), LukAB, LukED, LukMF
  • PHENOL SOLUBLE MODULINS (PSM) = Causes lipid bilyaer of host cells to break down through aggregation - lysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens when these toxins are released in the nose?

A
  • Alpha toxins and PSMs prevent phagolysosome formation by blocking fusion of the lysosome with the phagosome
  • PSMs will kill any cohabiting bacteria in the nose giving S.aureus an advantage by reducing competition
  • PSMs will have surfactant properties and allow S.aureus to slide across surfaces (as its not too motile on its own)
  • Biofilm formationAlpha toxins enable bacteria to attach to a surface and grow, beta toxins aid in secondary structure formation, PSMs allow for further growth and detachment so bacteria can go and disperse to new sites of infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Expand on the genetics of exotoxins

A
  • Can be encoded by chromosomal geens
    • Shinga toxin in Shingella Dysenteriae, TcdA and TcdB in C.dificile
  • Many toxins are also encoded by extrachromosomal genes
    • Plasmids – Bacillus anthracis toxin, tetanus toxin
    • Lysogenic bacteriophage e.g. streptococcal pyrogenic exotoxins in Scarlet Fever, Diphtheria toxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can exotoxins be classified?

A
  1. Membrane Acting Toxins = Type I
  2. Membrane Damaging Toxins = Type II
  3. Intracellular Toxins = Type III
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe Type I Exotoxins

A

These are MEMBRANE ACTING

They act from without the cell and interfere with host signalling by inappropriate activation of host cell receptors on membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give some examples of target receptors that type I exotoxins receptors activate

A

Target receptors include:

  • Guanylyl cyclase increase intracellular cGMP
  • Adenyl cyclase increase intracellular cAMP
  • Rho proteins
  • Ras proteins

See notes for E.Coli heat stable toxin

Heat stable toxin binds to the GC-C receptor and producing cGMP acts on CFTR which increases electrolyte secretion (Cl-,HCO3-) = secretory diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe type II Exotoxins

A
  • These are MEMBRANE DAMAGING
    1) Insert channels into host cell membrane
  • β sheet toxins e.g S.aureus α-toxin, γ toxin, PVL
  • α helix toxins à e.g diptheria toxin

2) Enzymatic damage e,g S. aureus β-haemolysin, PSM

These can either be receptor mediated or receptor independant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe type III Exotoxins

A
  • These are INTRACELLULAR TOXINS

There are usually two components one with allows toxin entry and one which causes damage

  • Receptor binding and translocation function - B
  • Toxigenic (enzymatic) – A
  • May be single or multiple B units e.g. Cholera toxin AB5

Some bacteria will also contain a needle like system through which they can directly insert the toxin inside the cell without receptor interaction e.g CagA in H.Pylori

17
Q

In intracellular toxins, the enzymatic component A has a variety of activities.

List some of them

A
  • ADP – ribosyl transferases - e.g. Exotoxin A of Pseudomonas aeruginosa, pertussis toxin.
  • Glucosyltransferases – e.g. TcdA and TcdB of Clostridium difficile
  • Deamidase – e.g. dermonecrotic toxin of Bordetella pertussis.
  • Protease – e.g. Clostridial neurotoxins: botulism & tetanus
  • Adenylcyclase - e.g. EF toxin of Bacillus anthracis
18
Q

Expand on superantigens and cytokines

A

Exotoxins are able to induce inflammatory cytokine release IL1, IL1β, TNF, IL 6,δ interferon, IL18

MECHANSIMS:

1) Superantigen – nonspecific bridging of the MHC Class II and T- cell receptor leading to cytokine production.

E.g. Staphylococcal Exfoliative Toxin A, Toxic Shock Syndrome Toxin 1 (TSST1)

2) Inflammasome which will detect damage to cells and results in activation of the different inflammasome leading to the release of IL1β and IL18 e.g. S. aureus toxin A, PVL.

19
Q

Expand on vaccines, toxoid and antibodies

A
  • Toxins can be inactivated using formaldehyde or glutaraldehyde ⇒ Toxoids
    • Toxoids are inactive proteins but are still highly immunogenic and form the basis of vaccines
      • Tetanus Vaccine
      • Diphtheria
      • Pertussis (acellular)
  • Treatment of toxin mediated disease can be affected by administering preformed antibodies to the toxin
    • Diphtheria antitoxin ⇒ Horse antibodies
  • Diphtheria toxin injected into horses and antibodies produced are taken and administered to humans
    • Tetanus ⇒ Pooled human immunoglobulin. Specific or Normal
    • Botulism ⇒ Horse antibodies
  • Experimental and research – monoclonal antibodies
20
Q

Provide two examples of toxin mediated diseases

A
  1. Clostridium difficile
  2. Verocytotoxin Escherichia Coli (VTEC) (STEC) disease
21
Q

Describe the microbiology of clostridium difficle

A
  • Gram positive bacillus
  • Anaerobic (only grows in absence of oxygen)
  • Spore-forming
  • Toxin-producing
  • Can be carried asymptomatically in the gut
  • Produces 3 toxins
22
Q

What is the epidemiology of Clostridium difficle?

A
  • Common hospital acquired infection
  • Spread by ingestion of spores ⇒ Remains dormant in environment
  • Its a coloniser of human gut up to 5% in adults
  • RISK FACTORS
    • Antibiotic use
    • Age
    • Antacids
    • Prolonged hospital stay
23
Q

How do antibiotics cause C.difficle?

A
  • Disrupt the microbial ecosystem within the gut
  • Antibiotics provide a competitive advantage to spore forming anaerobes in comparison to non-spore forming anaerobes
    • Allows C.difficle colonisation and growth
24
Q

What antibiotics are more likely to cause diseases like C.difficle?

A
  • 2nd and 3rd generation cephalosporins
  • Quinolones (ciprofloxacin)
  • Clindamycin
25
Q

What antibiotics are less like to cause disease?

A
  • Aminoglycosides
  • Trimethoprim
  • Vancomycin
26
Q

What are the toxins in C.difficle?

A
  • Cytotoxin A ⇔ TcdA coded by the tcdA gene
  • Cytotoxin B ⇔TcdB coded by the tcdB gene
  • Binary toxin ⇔ C.diff transferase (CDT) – minor role in disease
  • Tcd A and Tcd B →Type III AB toxins.
  • The A component of toxins are glycosylating enzymes
27
Q

Describe the mechanism of the TcdA and TcdB toxin

A
  1. Toxin will bind to specific host cell receptors
  2. The toxins are internalised by the cell
  3. The endosome in which the toxin is in is acidified
  4. There is pore formation on the endosome
  5. GTD is released from endosome to the host cell cytoplasm
  6. Rho GTPases are inactivated by glycosylation
  7. Down stream effects (cytopathic and cytotoxic effects)
28
Q

What are some of the effects of inactivated Rho GTPases in the cell?

A

CYTOPATHIC

  • Cytoskeleton breakdown
  • Loss of cell-cell contacts
  • Increased epithelial cell permeabillity

CYTOTOXIC

  • Activation of inflammasome
  • Increase in ROS levels
  • Induction of programmed cell death
29
Q

What are some symptoms of C.difficle disease?

A
  • Asymptomatic
  • Water diarrhoea
  • Dysentry
  • Psuedomembranous colitis
  • Toxic megacolon and peritonitis
30
Q

How do we diagnose for C.difficle?

A
  • Clinical signs and symptoms
    • Raised white cell count in blood
    • Detection of organisms and toxins in stool
    • 2 phase Test
      • Glutamate dehydrogenase → Detects if C.difficile organism present
      • Toxin enzyme linked immunosorbent assay (ELISA) for TcdA and TcdB toxins
  • Detection of tcdA and tcdB genes – PCR
  • Colonoscopy – pseudomembranous colitis
31
Q

How do you treat for C.difficle?

A
  • Treatment depends on severity and presence of surgical complications
  • Ideally remove offending antibiotic
  • Surgery - partial/ total colectomy
  • Recurrent C.difficle is treated via a faecal transplant
    • Will restablish the microbiota
32
Q

What is the VTEC/STEC disease?

A
  • VTEC, or Shiga-toxin (Stx) producing E. coli (STEC) can cause disease mild to life threatening disease.
  • Stx carried by some E. coli – most commonly O157:H7Identified usually by growth on sorbitol MacConkey agar (SMac)
    • E.Coli does not ferment sorbitol and hence is clear.
  • Other less common types not identified using SMac.
33
Q

What is the epidemiology of VTEC/STEC?

A
  • E. coli O157:H7 naturally colonizes the gastrointestinal tracts of cattle who are generally asymptomatic.
  • Transmission
    • Predominantly via consumption of contaminated food and water
    • Person to person, particularly in child day-care facilities, and from
    • Animal to person. E.g. in petting zoos, dairy farms, or campgrounds.
    • Very low infectious dose
34
Q

What is the pathogenesis of the toxins of VTEC?

A
  • Toxin – Shiga like toxin (SLT) = shigatoxin (Stx) = verocytotoxin (VTEC)
  • Stx, Stx1, Stx1a, 1c, 1d Stx2a, 2c, 2d – variations in a.a. sequence
  • Gene carried on lysogenic bacteria.
  • Type III exotoxin – AB5
    • Enzymatic component A = N-Glycosidase
    • Bound to 5 B subunits
35
Q

Describe the mechanism of the Shigatoxin

A
  1. Toxin will bind to receptors on the surface Gb3 and Gb4
  2. Bound toxin is internalised by receptor mediated endocytosis
  3. Carried by retrograde trafficking via the Golgi apparatus to the ER
  4. The A subunit (active component) is cleaved off by membrane bound proteases
  5. Once in cytoplasm A1 and A2 dissociate
  6. A1 will bind to the 28S RNA subunit → Blocking protein synthesis
36
Q

Describe the pathogenesis of STEC

A
  • STEC will adhere to epithelial cells of gut mucosa
  • The route by which Stx is transported from the intestine to the kidney and other tissues is debated
  • Bind to glomerular endothelial cells of kidney, CVS and CNS
  • Very high levels of Gb3 in kidney so kidney mainy affected
  • Thought that Stz favours inflammation resulting in microvascular thrombosis and inhibition of fibrinolysis
37
Q

Describe the STEC disease

A
  • Can be severe and life threatening
  • Children < 5 years greatest risk
  • Abdominal cramps, watery or bloody diarrhoaea = may not be present
    • Haemolytic ureamic syndrome
      • Anaemia - clots cause RBC’s to break down
      • Renal failure
      • Thromocytopenia
    • Less common are neurological symptoms
      • Lethargy
      • Severe headache
      • Convulsions
      • Encephalopathy
38
Q

What is the diganosis and treatment of STEC?

A

Diagnosis

  • Stool culture = Growth SMac
  • PCR for Stx genes

Treatment

  • Supportive including renal dialysis and blood product transfusion
  • Antibiotics have little or no role